Bruce Montgomery

25.1k total citations · 6 hit papers
244 papers, 10.4k citations indexed

About

Bruce Montgomery is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Bruce Montgomery has authored 244 papers receiving a total of 10.4k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Pulmonary and Respiratory Medicine, 74 papers in Oncology and 55 papers in Cancer Research. Recurrent topics in Bruce Montgomery's work include Prostate Cancer Treatment and Research (139 papers), Hormonal and reproductive studies (38 papers) and Prostate Cancer Diagnosis and Treatment (30 papers). Bruce Montgomery is often cited by papers focused on Prostate Cancer Treatment and Research (139 papers), Hormonal and reproductive studies (38 papers) and Prostate Cancer Diagnosis and Treatment (30 papers). Bruce Montgomery collaborates with scholars based in United States, Australia and Canada. Bruce Montgomery's co-authors include Peter S. Nelson, Elahe A. Mostaghel, Robert L. Vessella, Johann S. de Bono, Lawrence D. True, Howard I. Scher, Kenneth J. Pienta, Gerald V. Doyle, H. Tissing and Michael Craig Miller and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Bruce Montgomery

234 papers receiving 10.2k citations

Hit Papers

Circulating Tumor Cells Predict Survival Benefit from Tre... 2008 2026 2014 2020 2008 2008 2009 2011 2018 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
    2008 1.7k citations Johann S. de Bono, Howard I. Scher et al. Clinical Cancer Research profile →
  2. Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
    2008 1.1k citations Bruce Montgomery, Elahe A. Mostaghel et al. Cancer Research profile →
  3. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion
    2009 675 citations Elahe A. Mostaghel, Peter S. Nelson et al. profile →
  4. Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
    2011 474 citations Elahe A. Mostaghel, Brett T. Marck et al. Clinical Cancer Research profile →
  5. Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
    2018 384 citations Peter S. Nelson, Johann S. de Bono et al. profile →
  6. Prostate Cancer
    2025 34 citations Bruce Montgomery et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Montgomery United States 47 6.1k 3.6k 3.2k 3.2k 1.6k 244 10.4k
Samuel R. Denmeade United States 56 4.3k 0.7× 2.6k 0.7× 2.2k 0.7× 4.4k 1.4× 1.1k 0.7× 223 9.8k
Ladan Fazli Canada 61 4.4k 0.7× 2.7k 0.8× 2.9k 0.9× 6.4k 2.0× 898 0.6× 250 11.2k
David F. Jarrard United States 49 5.0k 0.8× 2.1k 0.6× 2.0k 0.6× 4.0k 1.3× 683 0.4× 207 10.0k
Christopher P. Evans United States 58 4.9k 0.8× 1.8k 0.5× 3.6k 1.1× 5.1k 1.6× 731 0.5× 250 10.3k
Zoran Čulig Austria 61 5.7k 0.9× 3.2k 0.9× 2.9k 0.9× 5.5k 1.7× 2.0k 1.3× 221 11.7k
Joanne Edwards United Kingdom 53 3.0k 0.5× 3.0k 0.8× 2.3k 0.7× 4.6k 1.4× 661 0.4× 264 9.1k
Donna M. Peehl United States 61 3.5k 0.6× 2.3k 0.6× 2.2k 0.7× 5.6k 1.7× 1.7k 1.1× 211 11.8k
Helmut Klocker Austria 67 6.6k 1.1× 3.0k 0.8× 3.1k 1.0× 6.9k 2.2× 2.4k 1.5× 364 15.1k
Yu Chen United States 45 3.7k 0.6× 2.0k 0.6× 1.7k 0.5× 4.3k 1.4× 800 0.5× 171 9.4k
Wayne D. Tilley Australia 69 5.2k 0.9× 3.3k 0.9× 3.2k 1.0× 6.5k 2.0× 2.4k 1.5× 213 12.9k

Countries citing papers authored by Bruce Montgomery

Since Specialization
Citations

This map shows the geographic impact of Bruce Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Montgomery more than expected).

Fields of papers citing papers by Bruce Montgomery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Montgomery. The network helps show where Bruce Montgomery may publish in the future.

Co-authorship network of co-authors of Bruce Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Montgomery. A scholar is included among the top collaborators of Bruce Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Montgomery. Bruce Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shan, Alicia Y. W. Wong, Vipul Bhatia, et al.. (2024). A combinatorial genetic strategy for exploring complex genotype–phenotype associations in cancer. Nature Genetics. 56(3). 371–376. 6 indexed citations
2.
Bakaloudi, Dimitra Rafailia, Fady Ghali, Yaw A. Nyame, et al.. (2024). Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer. Clinical Genitourinary Cancer. 22(3). 102100–102100. 3 indexed citations
3.
Mo, George, Laura Graham, Roman Gulati, et al.. (2024). Genomic Correlates of Prostate-Specific Membrane Antigen Expression and Response to 177Lu-PSMA-617: A Retrospective Multicenter Cohort Study. JCO Precision Oncology. 8(8). e2300634–e2300634. 7 indexed citations
4.
Gulati, Roman, Heather H. Cheng, Jessica E. Hawley, et al.. (2024). Hematologic toxicity in 177lu-PSMA-617 treatment for mCRPC: Unraveling the impact of PSMA PET bone tumor volume (PSMA-bTTV).. Journal of Clinical Oncology. 42(16_suppl). 5075–5075. 3 indexed citations
5.
McKay, Rana R., Lucia Kwak, Jett Crowdis, et al.. (2021). Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clinical Cancer Research. 27(13). 3610–3619. 21 indexed citations
6.
Mostaghel, Elahe A., Brett T. Marck, Orpheus Kolokythas, et al.. (2021). Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer. Clinical Cancer Research. 27(21). 6001–6011. 17 indexed citations
7.
McKay, Rana R., Huihui Ye, Wanling Xie, et al.. (2019). Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone. Journal of Clinical Oncology. 37(11). 923–931. 76 indexed citations
8.
Sowalsky, Adam G., Huihui Ye, Manoj Bhasin, et al.. (2018). Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations. Cancer Research. 78(16). 4716–4730. 38 indexed citations
9.
Mostaghel, Elahe A., Eunpi Cho, Ailin Zhang, et al.. (2017). Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer. Clinical Cancer Research. 23(16). 4592–4601. 31 indexed citations
10.
McKay, Rana R., Lillian Werner, Elahe A. Mostaghel, et al.. (2016). A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 23(4). 935–945. 28 indexed citations
11.
Zhang, Xiaotun, Ilsa M. Coleman, Lisha G. Brown, et al.. (2015). SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 21(20). 4698–4708. 129 indexed citations
12.
Montgomery, Bruce, Mario A. Eisenberger, Matthew B. Rettig, et al.. (2015). Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(6). 1356–1363. 64 indexed citations
13.
Lucas, Jared M., Cynthia Heinlein, Tom Kim, et al.. (2014). The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis. Cancer Discovery. 4(11). 1310–1325. 338 indexed citations
14.
Sowalsky, Adam G., Shuai Gao, Changmeng Cai, et al.. (2014). Abiraterone Treatment in Castration-Resistant Prostate Cancer Selects for Progesterone Responsive Mutant Androgen Receptors. Clinical Cancer Research. 21(6). 1273–1280. 139 indexed citations
15.
Wright, Jonathan L., Erika M. Kwon, Elaine A. Ostrander, et al.. (2011). Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes. Cancer Epidemiology Biomarkers & Prevention. 20(4). 619–627. 120 indexed citations
16.
Mostaghel, Elahe A., Brett T. Marck, Stephen R. Plymate, et al.. (2011). Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants. Clinical Cancer Research. 17(18). 5913–5925. 474 indexed citations breakdown →
17.
Wang, Diping, Bruce Montgomery, Lucy J. Schmidt, et al.. (2009). Reduced Tumor Necrosis Factor Receptor–Associated Death Domain Expression Is Associated with Prostate Cancer Progression. Cancer Research. 69(24). 9448–9456. 22 indexed citations
18.
Bono, Johann S. de, Howard I. Scher, Bruce Montgomery, et al.. (2008). Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 14(19). 6302–6309. 1744 indexed citations breakdown →
19.
Montgomery, Bruce, Elahe A. Mostaghel, Robert L. Vessella, et al.. (2008). Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth. Cancer Research. 68(11). 4447–4454. 1083 indexed citations breakdown →
20.
Moscatello, David K., Marina Holgado-Madruga, David R. Emlet, Bruce Montgomery, & Albert J. Wong. (1998). Constitutive Activation of Phosphatidylinositol 3-Kinase by a Naturally Occurring Mutant Epidermal Growth Factor Receptor. Journal of Biological Chemistry. 273(1). 200–206. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel R. Denmeade Breakdown of academic impact, for papers by Ladan Fazli Breakdown of academic impact, for papers by David F. Jarrard Breakdown of academic impact, for papers by Christopher P. Evans Breakdown of academic impact, for papers by Zoran Čulig Breakdown of academic impact, for papers by Joanne Edwards Breakdown of academic impact, for papers by Donna M. Peehl Breakdown of academic impact, for papers by Helmut Klocker Breakdown of academic impact, for papers by Yu Chen Breakdown of academic impact, for papers by Wayne D. Tilley
Rankless by CCL
2026